Lardinois, F. (01 March 2024). Therapeutic resistance of cancer stem cells in colorectal cancer: Role of MG stress [Paper presentation]. GIGA CANCER Meeting. |
Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., Roncarati, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., Janji, B., & Bellahcene, A. (06 February 2024). Exploring the impact of methylglyoxal stress on tumor immunity [Poster presentation]. Séminaire Télévie 2024. |
Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., Roncarati, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., Janji, B., & Bellahcene, A. (27 October 2023). Methylglyoxal stress : a novel role in tumor immunity ? [Poster presentation]. Annual Meeting of the Belgian Association for Cancer Research (BACR). |
Lardinois, F., Crake, R., Bellier, J., Vara Messler, M., Richiardone, E., Peulen, O., Corbet, C., & Bellahcene, A. (27 October 2023). The role of methylglyoxal stress in developing acquired resistance to cetuximab in quadruple wild-type colorectal cancer [Poster presentation]. BACR - Belgian Association for Cancer Research. |
Crake, R., Gasmi, I., Dehaye, J., Lardinois, F., Peiffer, R., Maloujahmoum, N., Agirman, F., KOOPMANSCH, B., D’Haene, N., Azurmendi Senar, O., Arsenijevic, T., Lambert, F., Peulen, O., Van Laethem, J.-L., & Bellahcene, A. (17 May 2023). Resistance to Gemcitabine in Pancreatic Cancer Is Connected to Methylglyoxal Stress and Heat Shock Response. Cells, 12 (10), 1414. doi:10.3390/cells12101414 Peer Reviewed verified by ORBi |
Lardinois, F., Crake, R., Bellier, J., Vara Messler, M., Richiardone, E., Peulen, O., Corbet, C., & Bellahcene, A. (21 February 2023). Role of methylglyoxal stress acquired resistance to cetuximab in quadruple wild-type colorectal cancer [Poster presentation]. Drugging and Regulating the MAP Kinase Pathway. |
Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., Roncarati, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., & Janji, B. (2023). Enhancement of anti-tumor immunity through interference with glycation stress in breast cancer [Poster presentation]. GIGA day. |
Lardinois, F., Crake, R., Bellier, J., Vara Messler, M., Richiardone, E., Peulen, O., Corbet, C., & Bellahcene, A. (30 September 2022). Role of methylglyoxal stress in acquired resistance to EGFR-targeted therapy in quadruple wild-type colorectal cancer [Poster presentation]. BACR - Belgian Association for Cancer Research, Ghent, Belgium. |
Lardinois, F., Crake, R., Bellier, J., Vara Messler, M., Richiardone, E., Peulen, O., Corbet, C., & Bellahcene, A. (09 September 2022). Methylglyoxal Stress and Acquired Resistance to EGFR-Targeted Therapy in Colorectal Cancer [Poster presentation]. INTERUNIVERSITY PHD STUDENT DAY, Namur, Belgium. |
Lardinois, F., Crake, R., Bellier, J., Vara Messler, M., Richiardone, E., Peulen, O., Corbet, C., & Bellahcene, A. (22 June 2022). Acquired resistance to Cetuximab in quadruple wild-type colorectal cancer: role of methylglyoxal stress [Poster presentation]. EACR - European Association for Cancer Research, Séville, Spain. |
Lardinois, F., Crake, R., Bellier, J., Vara Messler, M., Richiardone, E., Peulen, O., Corbet, C., & Bellahcene, A. (December 2021). Acquired resistance to EGFR-targeted therapy in quadruple wild-type colorectal cancer: role of methylglyoxal stress [Poster presentation]. GIGA-Cancer Day, Liège, Belgium. |